<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: K.A.H.R. FOUNDATION -->
          <cik>0002125078</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Class A Common Stock, par value $0.0001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>05/18/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0002121708</issuerCik>
        <issuerName>Imricor Medical Systems, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>000000000</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>400 Gateway Blvd.</com:street1>
          <com:city>Burnsville</com:city>
          <com:stateOrCountry>MN</com:stateOrCountry>
          <com:zipCode>55337</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>K.A.H.R. FOUNDATION</reportingPersonName>
      <citizenshipOrOrganization>MN</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>31023094.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>31023094.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>31023094.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>8.89</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Imricor Medical Systems, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>400 Gateway Blvd.,Burnsville, Minnesota</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>K.A.H.R. Foundation</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>4305 Trillium Way, Minnetrista, MN 55346</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Minnesota</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>31,023,094 shares of Common Stock underlying the same amount of CDIs, consisting of (a) 2,951,661 shares of Common Stock underlying the same amount of CDIs held by the Reporting Person, (b) 1,950,840 shares of Common Stock underlying the same amount of CDIs issuable upon exercise of certain warrants held by the Reporting Person, and (c) 26,120,593 shares of Common Stock underlying the same amount of CDIs issuable upon conversion of certain outstanding convertible notes held by the Reporting Person within 60 days after May 18, 2026. "CDIs" are Clearing House Electronic Subregister System Depositary Interests, which are units of beneficial ownership interest in the Common Stock.</amountBeneficiallyOwned>
        <classPercent>8.89%, based on 320,947,028 shares of Common Stock outstanding as of April 21, 2026, as the Issuer reported in its Form 10 filed on April 24, 2026, plus the 26,120,593 shares of Common Stock underlying the same amount of CDIs issuable upon conversion of the Reporting Person's convertible notes, plus the 1,950,840 shares of Common Stock underlying the same amount of CDIs issuable upon exercise of certain warrants held by the Reporting Person.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>31,023,094</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>31,023,094</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>
      </item10>
    </items>
    <exhibitInfo>Not applicable.</exhibitInfo>
    <signatureInformation>
      <reportingPersonName>K.A.H.R. FOUNDATION</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Jeannine M. Rivet</signature>
        <title>Jeannine M. Rivet/President</title>
        <date>05/20/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
